Every January, ii important conferences bestow together the electronics and healthcare sectors, bounteous us a glimpse of what's truly on the cutting edge in diabetes.

The JP Morgan Healthcare conference for investors and industry execs kicked off in San Francisco this calendar week, following last week's gi-normous Consumer Electronics Show (CES) in Las Vegas — a bonanza of the modish and greatest gadgets and technology that hosts over 3,600 companies across 2.4 trillion lawful feet of exposition space.

Among the super-cool stuff displayed CES 2016 were a futuristic robot named Pepper (hailed as "the closest thing to Rosie from The Jetsons yet"); countless smartwatches including the new Fitbit smartwatch; any act of new smart TVs and appliances that are all interconnected; and much, much more.

Of course, healthcare has been an emerging focus at CES for some six long time today with the gaolbreak Digital Wellness Summit held there, and diabetes is always a key matter.

Today we're looking approximately of the coolest announcements — with respectfulness to diabetes — in the healthcare sphere of CES 2016. (Stay adjusted for our coverage of the JPM event early next week.)

Medtronic made the biggest wellness headlines at CES, mainly by showcasing its partnership with IBM Watson Health originally announced in April 2014. Specifically, IBM's CEO Ginni Rometty delivered the event keynote, focalisation happening the cognitive computing intelligence known as IBM John Broadus Watson that's being matched with medical and consumer electronic devices — including the Minimed pump-CGM combo. Medtronic CEO Omar Ishrak joined her on stage for a demo of a new app that has the capacity to bode hypoglycemia ternion hours advanced of it occurring (!) This is apparently at version 1.0 of the companies' collaboration, and information technology's in the process of being reviewed by FDA with an expected launch in the U.S. this summer.

Information technology was just a brief present alongside several others not related to diabetes, so inside information were scarce. We reached out to Medtronic for more specifics and spokeswoman Amanda Sheldon tells us this:

So far, this new this James Dewey Watson app does not have a name and final features are TBD. IT's simply being described as an extension of the Minimed Connect data-viewing system launched last Fall. Pricing will be discovered closer to launch, and Sheldon says it will be disposable on both iOS and Android devices.

"We programme to have John Broadus Watson synthesize information from Medtronic insulin pumps and CGM devices — elaborate information like the rate of insulin delivered, the constantly unsteady glucose level and carbohydrate intake information. The app may also integrate information sources like wearable activeness trackers, digital scales, geo-emplacemen data, calendar inside information and even the brave out, to develop more valuable and personalized insights," Sheldon says.

"IBM and Medtronic also intend to partner with other companies and incorporate their data and expertise in areas such as alimentation. Away combining new information sources and analyzing it in new ways, we hope to develop tools that volition meliorate citizenry's ability to deal their diabetes."

Note that this is isolable from the Minimed 640G device, the next generation pump-CGM combo system that toilet anticipate hypos up to 30 minutes in advance and suspend insulin to foreclose those Lows. The under-development 640G (expected to be filed with the FDA new this year) only looks at glucose values from the CGM sensor, while the new Watson app will own much deeper analytical capabilities.

"With IBM Watson, we are looking at all the contextual data from a variety of data sources to recognize patterns — those for an individual or patterns of groups of people WHO are alike," Sheldon explains. "This would enable us to make predictions with a high level of accuracy up to 3 hours front. This will help the person with diabetes make more informed decisions. However, this app would not take action such as the MiniMed 640G would coiffure."

Sounds very precooled, and the demo broadcast vital during the CES keynote was bad impressive. Course, the predictions are only As redeeming as the data supplied, so let's hope some gaps in sensor truth and patient reporting get into't get in the way.

Looking forward to sightedness this in the summer, Medtronic and IBM Watson!

Speaking of partnerships, Panasonic was also represented at CES, which is noteworthy for our D-Residential district because the electronics company venture famous as Panasonic Healthcare acquired Bayer Diabetes Care last summer and the deal closed aboriginal this year. Just recently, Bayer customers have been receiving letters about this change and how the former Bayer bequeath nowadays be titled Ascensia Diabetes Care below Panasonic. We asked Medtronic if this changes anything in regard to their glucose meters that link to Minimed pumps, and were told by Sheldon that "it doesn't change anything."

Anyone call back the all-in-one YoFiMeter that we profiled in ahead of time 2014? At this yr's CES consequence, sound tech giant AT&T proclaimed that information technology has teamed up with this La Jolla, CA, company (YoFi was previously partnered functioning with Qualcomm). The take is to enable PWDs (people with diabetes) to wirelessly transmit their blood sugar results, plus "other biometric information and vocalisation notes" to providers and caregivers over AT&T's extremely fail-safe electronic network. This is being reviewd by FDA right away, "with yield expectable to start in early 2016," according to the announcement.

A trifle smaller and thicker than an early-generation iPhone, this YoFiMeter has two cassettes in spite of appearanc: unmatched with 20 try strips (one-half the length of a regular pillage because you never touch them, differently to employ blood) and a cassette with 20 lancets. It has matchless button that activates the entire system, another that fires the lancet, and a third that disposes of the used strip. It sports a color relate screen, and a "recording device" built into the meter that does away with the need for manual come logging, because you can speak your results!

The meter automatically sends run results to the cloud, and the cell air time is integrated into the monetary value of the strip cassette so you don't need to subscribe with a carrier, we'atomic number 75 told.

Patently, we'Re always a trifle sceptical just about these entirely-inclusive glucose meters, which suffer practised years of delay at the Food and Drug Administration gate in the historical. Still, IT's encouraging to get a line the recent FDA approval of the Dario all-in-one meter, made by Israel-based LabStyle Innovations. That m is expected to set in motion in the States very soon, thusly that may foreshadow recovered for YoFiMeter and AT&T hither.

French wellness company VisioMed introduced its so-called Bewell Connect organization, which includes a smartphone app that communicates with a number of variant coupled devices like a glucose meter, thermostat, blood pressure proctor, and blood O sensor. Every last of them have names that start with My, so the glucose metre e.g. would be MyGluco.

The troupe pitches this as a "virtual medical" toolset, but information technology goes on the far side that by allowing the exploiter to share the data with a MD just by pushing a button on the mobile app via their BewellCheck-Up feature. In Anatole France where it's presently available, the app locates nearby providers in the national medical service. VisioMed says that aboard working to gain FDA clearance for its meter, it's also workings to establish a network of connected physicians in the U.S. for a similar service. On the company's website, the MyGluco device is listed at an expected price point of $99, but who knows if it will really cost that if and when it hits the market present in the U.S.?

Going a measure beyond the Bewell conception was something titled the Lumee, a new world-wide biosensor unveiled at CES by San Francisco inauguration Profusa.

This is a single sensor that can ceaselessly supervise a salmagundi of body alchemy stats, including glucose and oxygen levels, essence charge per unit, ventilatio and to a greater extent, and securely transmit the data anywhere via a smartphone app.

Physically, it's reminiscent of the Abbott Libre glucose cheap technology, that includes a small 3-5 milimeter detector adhered to the tegument, with readings taken past the substance abuser by satisfactory a ramify optical reader over information technology to pick sprouted the light signal.

Profusa explains the scientific discipline behind it this way: "Each biosensor is comprised of a bioengineered 'smart hydrogel' (similar to contact material) forming a porous, tissue paper-integrating scaffold that induces capillary and cellular in-growth from surrounding weave. The streetwise gel is linked to a spark-emitting molecule that contin­uously signals the comportment of a body chemical such Eastern Samoa oxygen, glucose, or other biomarker."

Apparently this could likewise be used for checking complications wish diabetic ulcers, arteria and nervus wrong, and strange issues where O levels inside the body are turned.

This is investigational at this point and still in clinical trials, and no timeline has been announced yet for regulatory review. Merely we're pretty sure this is a coup d'oeil into the futurity of "biosensing," in which CGM will be concerted with taking unusual somatogenetic readings in a uniform sensor.

One of the coolest new gadgets disclosed at the CES Health Summit this year was the DietSensor, which is actually the brainchild of two parents of a fry with type 1.

This pocket-sized food scanning device and mobile app with coaching feature is the first of its kind to hitting the consumer market, and IT was actually named a "Best of Innovation Awards Honoree" at CES 2016, honoring it as ace of the 27 best member innovations in the human beings. It uses SCiO, a building block sensor that helps you reckon out the chemical war paint of your food or drunkenness by analyzing how the molecules interact using reddened. Wow – futuristic stuff!

Artificer and D-Dad Remy Bonnasse and married woman Astrid came up with the idea in 2014 afterwards their 9-year-nonmodern daughter was diagnosed with T1D and they searched for a way to easily track carbs and dose insulin.

To utilization the DietSensor, you just hold a small scanner over the food and click the button to sunlit up the skeletal hand-held device the size of a pager, and it takes a photo and transmits that to the smartphone DietSensor app to magistrate the bulk. Then DietSensor reports back out with the nutritional value of the food for thought scanned based on the information stored in its database.

At the moment, it only can handle basic foods with i layer, like a piece of bread, burger cake, or slice of tall mallow; not a bowl of cereal OR sandwich. But the capability to treat to a greater extent complex foods is in the works, of course.

Rectify now, the database contains info connected 600,000 intellectual nourishment items, and this is perpetually being updated.

The DietSensor will personify available later in the yr, possibly by Fall. It is bad costly, with a price track of $249 for the SCIO detector itself and a $10 time unit subscription for the database connection. But Dedicated Carbonator! If this thing is even clean precise, what a helpful joyride!

Some other big food tool that caught our heart was the Nima food allergin detector past 6SensorLabs out of San Francisco.

It's a sleek black infinitesimal Triangulum device that you solidifying on the table where you're eating. You simply insert a food sample into its small dismissible tube capsule and insert that into the triangle to allow it to test for anything you may constitute hypersensitised to — gluten, peanuts, dairy, etc. Information technology can discover gluten down to 20 parts per million (ppm), which is pretty darn sensitive!

The results are displayed connected reactionist on the device: a smile if you're good to go without any allergins heard, or a frown if it finds any traces.

Of course, the Nima also has a companion app that connects via Bluetooth to the little triangle examiner for easy food trailing and reference work.

This one is too a little costly, at $199 for a starter motor outfit that includes three capsules operating room a starter kit + a 12-jam of capsules for $247. Additional capsules are more or less $4 for each one. The Nima is available for pre-order now and is anticipated to start shipping in middle-twelvemonth.

Massachusetts troupe NeuroMetrix declared FDA approval of its second-coevals pain relief wearable twist Quell. This is a very cold first-of-its-kind, drug-free choice for reduction the pain of neuropathy, sciatica, and strange chronic pain through neural pulses — delivered away a band clothed just below the knee, with a company app that allows users to change settings and lead sessions via a smartphone Beaver State iPad.

It was disclosed last summer (see our coverage here), and its makers boast that it is "clinically proven to start relieving degenerative pain in as little as 15 minutes… (with) FDA cleared prescription drug-strength technology that works with your own body away moving your nervousness and blocking anguish signals in your body."

The bran-new upgraded version with sprawly battery life and progressive sleep in tracking will be available in March, with a free upgrade program for existent Quell users World Health Organization send their earlier-gen devices back in for exchange.

Among the substance diabetes players described at CES were Dexcom, showing off their newest G5 Mobile system just approved last Fall, and featuring their "ecosystem approach to data" highlighting partnerships with Tidepool and Meal Memory, among others.

A handful of diabetes execs were also component of panel discussions at the CES Digital Health Summit, too. Amy Foley of JnJ Diabetes Solutions, World Health Organization accompanied several of these sessions famed how "successful mHealth technical school companies need to connect patients, data, and payers systematic to be telling." Amen!

Meanwhile, D-industry analyst David Kliff of Diabetic Investorhad this observation: "Every company has a Bluetooth-enabled meter right away, and the problem is that we're not pushing the edge of the envelope technical school-wise with that any longer… View it this way: When you go online and usance Google or Facebook, they'Ra collection pieces of information about us and fine-tuning what we see. I don't see ads for asthma, I see diabetes ads online. Diabetes companies postulate to catch that same kind of transmutation and more efficaciously tailor their messages based on that data."

That's a trifle creepy, just most likely an fatal part of our future in the diabetes mHealth world.

{Updates happening diabetes tech from #JPM2016 coming following week.}